Home
Market Capitalization of Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Ltd
NSE: BALAXI
Market Cap
Key Highlights
- The Market Cap of Balaxi Pharmaceuticals Ltd is ₹ 292.43 crore as of 07 May 25 .
- The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 53.8 as of 08 May 09:54 .
- The Dividend Payouts of Balaxi Pharmaceuticals Ltd is ₹ 0.5 as of Jul 01, 2022 .

Balaxi Pharmaceuticals Ltd
NSE: BALAXI
Share Price
Market Price of Balaxi Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
07 May 2025 | 52.97 |
06 May 2025 | 52.81 |
05 May 2025 | 53.97 |
02 May 2025 | 54.63 |
30 Apr 2025 | 55.16 |
29 Apr 2025 | 56.96 |
28 Apr 2025 | 57.7 |
25 Apr 2025 | 58.37 |
24 Apr 2025 | 60.27 |
23 Apr 2025 | 62.19 |
SWOT Analysis Of Balaxi Pharmaceuticals Ltd
BlinkX Score for Balaxi Pharmaceuticals Ltd
Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Balaxi Pharmaceuticals Ltd
Historical P/E Ratio of Balaxi Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Balaxi Pharmaceuticals Ltd
Historical Revenue of Balaxi Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Balaxi Pharmaceuticals Ltd
Historical EBITDA of Balaxi Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Balaxi Pharmaceuticals Ltd
Historical Net Profit of Balaxi Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Ltd
NSE: BALAXI
DIVIDENDPAYOUT
About Balaxi Pharmaceuticals Ltd
- Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
- The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
- The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
- The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.
Balaxi Pharmaceuticals Ltd News Hub
Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter
Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga
Read more
02 Aug 24
Balaxi Pharmaceuticals to conduct AGM
Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he
Read more
01 Aug 24
Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September
Read more
05 Nov 24
Balaxi Pharmaceuticals announces board meeting date
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20
Read more
30 Oct 24